The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kits Eyecare Ltd
TSX:KITS
|
CA |
|
Halozyme Therapeutics Inc
LSE:0J2O
|
US |
|
Mosaic Co
NYSE:MOS
|
US |
|
C
|
ClearVue Technologies Ltd
ASX:CPV
|
AU |
|
M
|
Megawatt Lithium and Battery Metals Corp
CNSX:MEGA
|
CA |
|
OneSpan Inc
NASDAQ:OSPN
|
US |
|
S
|
Simmtech Holdings Co Ltd
KOSDAQ:036710
|
KR |
|
M
|
Mitsui O.S.K. Lines Ltd
DUS:MILA
|
JP |
|
H
|
Hainan Manaslu Acquisition Corp
NASDAQ:ABLV
|
CN |
|
ICON PLC
NASDAQ:ICLR
|
IE |
Kits Eyecare Ltd (KITS)’s 12-month stock price forecast through November 2027 has a consensus target of CA$23.46, implying 32% upside. The forecast is based on price targets from 9 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
KITS is 23.46 CAD with a low forecast of 19.19 CAD and a high forecast of 27.83 CAD.
Over the last 7 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 3 years is 18%.
Over the last 7 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is 26%.
Over the last 7 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 57%.
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 2 years is 70%.
Over the last 7 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 77%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more